Holmium laser enucleation of the prostate (HoLEP) in short-circuit outpatient care: Is prostatic volume a limiting factor?

IF 1.5 4区 医学 Q3 UROLOGY & NEPHROLOGY
Sánchez Rodríguez Maria, Marco Franco, Roger Freixa Sala, Carlos Gasanz Serrano, Mauro Bernardello Ureta, Ramón Bultó Gonzalvo, Jordi Cervera Alcaide, Carla Casanova García, Mireia García Puche, Maria Segura Alabart, Juan José Areal Calama, Fernando Ágreda Castañeda
{"title":"Holmium laser enucleation of the prostate (HoLEP) in short-circuit outpatient care: Is prostatic volume a limiting factor?","authors":"Sánchez Rodríguez Maria,&nbsp;Marco Franco,&nbsp;Roger Freixa Sala,&nbsp;Carlos Gasanz Serrano,&nbsp;Mauro Bernardello Ureta,&nbsp;Ramón Bultó Gonzalvo,&nbsp;Jordi Cervera Alcaide,&nbsp;Carla Casanova García,&nbsp;Mireia García Puche,&nbsp;Maria Segura Alabart,&nbsp;Juan José Areal Calama,&nbsp;Fernando Ágreda Castañeda","doi":"10.1111/luts.12525","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction and Objectives</h3>\n \n <p>Our goals were to study prostatic volume as a limiting factor after HoLEP surgery with short-circuit outpatient care (4 h) and to define other factors that affect the success of the proposed circuit.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>An observational analysis and review was performed using a prospective database. Preoperative, intraoperative, and postoperative variables were included for patients who were scheduled for short-circuit outpatient care (SCOC) and who underwent HoLEP between 2020 and 2023. We defined SCOC as a postoperative hospital stay of 4 h. Subjects who required more than 4 h in hospital were categorized as conventional hospital admission (CHA). A descriptive populational study was conducted, expressing the mean using a 95% confidence interval and percentages for the continuous variables. In order to analyze them, we used the Student's <i>t</i>-test for the continuous variables and the chi-squared test for the categorical variables.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Sixty-eight patients were included, 54 of which completed SCOC, which represented a success ratio of 79.5%. The mean age and prostatic volume of the whole cohort were 68.9 (±6.8) years and 79.5 (±29.1) mL, respectively. We found no significant differences in age, prostatic volume, antiplatelet drug use, indwelling bladder catheter, or applied energy among the subjects who completed SCOC and those who required CHA. No patient was presented with a complication of Grade 3 (or higher) in the modified Clavien–Dindo classification. At the six-month follow-up, no differences were observed in the uroflowmetry or International Prostate Symptoms Score variables.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Prostatic volume does not seem to be a limiting factor after undergoing HoLEP with short-circuit outpatient care.</p>\n </section>\n </div>","PeriodicalId":18028,"journal":{"name":"LUTS: Lower Urinary Tract Symptoms","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"LUTS: Lower Urinary Tract Symptoms","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/luts.12525","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction and Objectives

Our goals were to study prostatic volume as a limiting factor after HoLEP surgery with short-circuit outpatient care (4 h) and to define other factors that affect the success of the proposed circuit.

Materials and Methods

An observational analysis and review was performed using a prospective database. Preoperative, intraoperative, and postoperative variables were included for patients who were scheduled for short-circuit outpatient care (SCOC) and who underwent HoLEP between 2020 and 2023. We defined SCOC as a postoperative hospital stay of 4 h. Subjects who required more than 4 h in hospital were categorized as conventional hospital admission (CHA). A descriptive populational study was conducted, expressing the mean using a 95% confidence interval and percentages for the continuous variables. In order to analyze them, we used the Student's t-test for the continuous variables and the chi-squared test for the categorical variables.

Results

Sixty-eight patients were included, 54 of which completed SCOC, which represented a success ratio of 79.5%. The mean age and prostatic volume of the whole cohort were 68.9 (±6.8) years and 79.5 (±29.1) mL, respectively. We found no significant differences in age, prostatic volume, antiplatelet drug use, indwelling bladder catheter, or applied energy among the subjects who completed SCOC and those who required CHA. No patient was presented with a complication of Grade 3 (or higher) in the modified Clavien–Dindo classification. At the six-month follow-up, no differences were observed in the uroflowmetry or International Prostate Symptoms Score variables.

Conclusions

Prostatic volume does not seem to be a limiting factor after undergoing HoLEP with short-circuit outpatient care.

短路门诊中的前列腺钬激光去核术(HoLEP):前列腺体积是限制因素吗?
简介和目标:我们的目标是研究前列腺体积作为HoLEP手术后短路门诊护理(4小时)的限制因素,并确定影响拟议电路成功的其他因素:使用前瞻性数据库进行观察分析和回顾。纳入了 2020 年至 2023 年期间计划接受短路门诊护理(SCOC)并接受 HoLEP 的患者的术前、术中和术后变量。我们将 SCOC 定义为术后住院时间不超过 4 小时。我们进行了一项描述性人口研究,使用 95% 的置信区间和百分比来表示连续变量的平均值。为了对其进行分析,我们对连续变量采用了学生 t 检验,对分类变量采用了卡方检验:共纳入 68 名患者,其中 54 人完成了 SCOC,成功率为 79.5%。整个组群的平均年龄和前列腺体积分别为 68.9 (±6.8) 岁和 79.5 (±29.1) mL。我们发现,完成 SCOC 和需要 CHA 的受试者在年龄、前列腺体积、抗血小板药物使用、留置膀胱导尿管或应用能量方面没有明显差异。根据修改后的 Clavien-Dindo 分级,没有患者出现 3 级(或以上)并发症。在六个月的随访中,尿流测量或国际前列腺症状评分变量均未出现差异:结论:前列腺体积似乎并不是接受短路门诊治疗的限制因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
LUTS: Lower Urinary Tract Symptoms
LUTS: Lower Urinary Tract Symptoms UROLOGY & NEPHROLOGY-
CiteScore
3.00
自引率
7.70%
发文量
52
审稿时长
>12 weeks
期刊介绍: LUTS is designed for the timely communication of peer-reviewed studies which provides new clinical and basic science information to physicians and researchers in the field of neurourology, urodynamics and urogynecology. Contributions are reviewed and selected by a group of distinguished referees from around the world, some of whom constitute the journal''s Editorial Board. The journal covers both basic and clinical research on lower urinary tract dysfunctions (LUTD), such as overactive bladder (OAB), detrusor underactivity, benign prostatic hyperplasia (BPH), bladder outlet obstruction (BOO), urinary incontinence, pelvic organ prolapse (POP), painful bladder syndrome (PBS), as well as on other relevant conditions. Case reports are published only if new findings are provided. LUTS is an official journal of the Japanese Continence Society, the Korean Continence Society, and the Taiwanese Continence Society. Submission of papers from all countries are welcome. LUTS has been accepted into Science Citation Index Expanded (SCIE) with a 2011 Impact Factor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信